Clinical Trial Update: Safety and Efficacy Study of CENV3 Vaccine to Protect Against HCV Infection [Phase 1, Phase 2]

View source ↗

Summary

This document provides an update on a Phase 1/2 safety and efficacy study of the CENV3 vaccine intended to prevent hepatitis C virus infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• CENV3 Vaccine (CENV3)

Snippet

Sponsor: National Liver Institute, Egypt | Conditions: Vaccine Overdose of Undetermined Intent | Phase 1, Phase 2 | Status: UNKNOWN